Literature DB >> 24745936

Widespread use of complementary and alternative medicine among non-Hodgkin lymphoma survivors.

Sarah Rausch Osian1, Alexis D Leal, Cristine Allmer, Matthew J Maurer, Grezegorz Nowakowski, David J Inwards, William R Macon, Shawna L Ehlers, George J Weiner, Thomas M Habermann, James R Cerhan, Carrie A Thompson.   

Abstract

There are few studies examining complementary and alternative medicine (CAM) use and beliefs among non-Hodgkin lymphoma (NHL) survivors. Seven hundred and nineteen patients with NHL from the University of Iowa/Mayo Clinic Molecular Epidemiology Resource who completed the 3-year post-diagnosis questionnaire were included in this study. Altogether 636 (89%) reported ever using CAM, with 78% utilizing vitamins, 54% alternative therapies and 45% herbals. Female gender was associated with increased overall CAM use (p=0.0001) as well as use of vitamins (p=0.0001), herbals (p=0.006) and alternative therapy (p=0.0002) for cancer. Older age (>60) was associated with increased vitamin use (p=0.005) and decreased herbal use (p=0.008). Among users, 143 (20%) believed CAM assists healing, 123 (17%) believed CAM relieves symptoms, 122 (17%) believed CAM gives a feeling of control, 110 (15%) believed CAM assists other treatments, 108 (15%) believed CAM boosts immunity, 26 (4%) believed CAM cures cancer and 36 (5%) believed CAM prevents the spread of cancer.

Entities:  

Keywords:  Complementary therapies; lymphoma; neoplasms; survivors; vitamins

Mesh:

Year:  2014        PMID: 24745936      PMCID: PMC4666508          DOI: 10.3109/10428194.2014.916803

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  30 in total

Review 1.  Drug interactions with herbal medicines.

Authors:  Souad Skalli; Abdelhamid Zaid; Rachida Soulaymani
Journal:  Ther Drug Monit       Date:  2007-12       Impact factor: 3.681

2.  Pilot study of a multimodal intervention: mixed-type exercise and psychoeducation in patients undergoing allogeneic stem cell transplantation.

Authors:  M Jarden; D Hovgaard; E Boesen; M Quist; L Adamsen
Journal:  Bone Marrow Transplant       Date:  2007-08-20       Impact factor: 5.483

Review 3.  [Use of complementary and alternative medicine by cancer patients: systematic review].

Authors:  Cristiane Spadacio; Nelson Filice de Barros
Journal:  Rev Saude Publica       Date:  2008-02       Impact factor: 2.106

4.  The use of traditional, complementary and alternative medicine in Sri Lankan cancer care: results from a survey of 500 cancer patients.

Authors:  A Broom; K Wijewardena; D Sibbritt; J Adams; K R Nayar
Journal:  Public Health       Date:  2010-04-03       Impact factor: 2.427

5.  Use of complementary therapies among breast and prostate cancer patients during treatment: a multisite study.

Authors:  D M Hann; F Baker; C S Roberts; C Witt; J McDonald; M Livingston; J Ruiterman; R Ampela; C Crammer; O Kaw
Journal:  Integr Cancer Ther       Date:  2005-12       Impact factor: 3.279

6.  Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.

Authors:  Matthew T Drake; Matthew J Maurer; Brian K Link; Thomas M Habermann; Stephen M Ansell; Ivana N Micallef; Jennifer L Kelly; William R Macon; Grzegorz S Nowakowski; David J Inwards; Patrick B Johnston; Ravinder J Singh; Cristine Allmer; Susan L Slager; George J Weiner; Thomas E Witzig; James R Cerhan
Journal:  J Clin Oncol       Date:  2010-08-16       Impact factor: 44.544

7.  Complementary and alternative medicine in patients with chronic lymphocytic leukemia.

Authors:  Manfred Hensel; Martin Zoz; Anthony D Ho
Journal:  Support Care Cancer       Date:  2008-05-06       Impact factor: 3.603

8.  Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study.

Authors:  Thomas M Habermann; Carrie A Thompson; Betsy R LaPlant; Brent A Bauer; Carol A Janney; Matthew M Clark; Teresa A Rummans; Matthew J Maurer; Jeff A Sloan; Susan M Geyer; James R Cerhan
Journal:  Am J Hematol       Date:  2009-12       Impact factor: 10.047

Review 9.  Dietary supplement use in cancer care: help or harm.

Authors:  Mary L Hardy
Journal:  Hematol Oncol Clin North Am       Date:  2008-08       Impact factor: 3.722

10.  Complementary and alternative medicine use among adults and children: United States, 2007.

Authors:  Patricia M Barnes; Barbara Bloom; Richard L Nahin
Journal:  Natl Health Stat Report       Date:  2008-12-10
View more
  5 in total

1.  Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.

Authors:  James R Cerhan; Brian K Link; Thomas M Habermann; Matthew J Maurer; Andrew L Feldman; Sergei I Syrbu; Carrie A Thompson; Umar Farooq; Anne J Novak; Susan L Slager; Cristine Allmer; Julianne J Lunde; William R Macon; David J Inwards; Patrick B Johnston; Ivana N M Micallef; Grzegorz S Nowakowski; Stephen M Ansell; Neil E Kay; George J Weiner; Thomas E Witzig
Journal:  Int J Epidemiol       Date:  2017-12-01       Impact factor: 7.196

Review 2.  Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.

Authors:  Moshe Frenkel; Kenneth Sapire
Journal:  Curr Oncol Rep       Date:  2017-10-14       Impact factor: 5.075

Review 3.  Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.

Authors:  John Baptist Asiimwe; Prakash B Nagendrappa; Esther C Atukunda; Mauda M Kamatenesi; Grace Nambozi; Casim U Tolo; Patrick E Ogwang; Ahmed M Sarki
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-17       Impact factor: 2.650

4.  From Disappointment to Holistic Ideals: A Qualitative Study on Motives and Experiences of Using Complementary and Alternative Medicine in Sweden.

Authors:  Jenny-Ann Danell
Journal:  J Public Health Res       Date:  2015-08-04

5.  Relaxation versus exercise for improved quality of life in lymphoma survivors-a randomised controlled trial.

Authors:  Suchita Hathiramani; R Pettengell; H Moir; A Younis
Journal:  J Cancer Surviv       Date:  2020-09-28       Impact factor: 4.442

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.